INT-1B3 miR-193a-3p Mimic Boosts T Cell Immunity and Induces Tumor Cell Death
August 5, 2024
Online ISSN: 1949-2553
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the
impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to
eliminate the border between specialties, to link different fields of biomedical science, and to
foster application of basic and clinical science to fight disease.
Prognostic and Therapeutic Insights Into MIF, DDT, and CD74 in Melanoma
July 26, 2024
PRESS RELEASE: On July 19, 2024, a new research paper was published in Oncotarget, entitled, “Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma.” continue reading »
Novel Triple-Drug Combination to Fight Pancreatic Cancer
July 25, 2024
In this new study, researchers unveiled a promising synergistic strategy for combating pancreatic cancer. continue reading »
Prevalence and Impact of the KIT M541L Variant in Patients With Mastocytosis
July 24, 2024
PRESS RELEASE: On July 22, 2024, a new research paper was published in Oncotarget, entitled, “Prevalence and impact of the KIT M541L variant in patients with mastocytosis.” continue reading »
Oncotarget Welcomes New Editorial Board Members
July 22, 2024
Oncotarget is also offering a 50% discount on publication fees until the end of the year. continue reading »